Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Long-Term Deferred Tax (2022 - 2024)

CV Sciences' Long-Term Deferred Tax history spans 3 years, with the latest figure at $17.1 million for Q4 2023.

  • For Q4 2023, Long-Term Deferred Tax changed N/A year-over-year to $17.1 million; the TTM value through Dec 2023 reached $17.1 million, changed N/A, while the annual FY2023 figure was $17.1 million, N/A changed from the prior year.
  • Long-Term Deferred Tax for Q4 2023 was $17.1 million at CV Sciences, up from $1.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $17.1 million in Q4 2023 and bottomed at $17.1 million in Q4 2023.